{"nctId":"NCT04402970","briefTitle":"Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)","startDateStruct":{"date":"2020-06-19","type":"ACTUAL"},"conditions":["SARS-CoV 2","ARDS"],"count":30,"armGroups":[{"label":"Inhaled/nebulized dornase alfa","type":"EXPERIMENTAL","interventionNames":["Drug: Dornase Alfa Inhalation Solution"]},{"label":"Standard of care","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Dornase Alfa Inhalation Solution","otherNames":["Pulmozyme"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age \\> 18 years\n* Hospitalized and mechanically ventilated for illness related to SARS-CoV-2\n* Confirmed positive SARS-CoV-2 infection by Polymerase chain reaction (PCR)\n* individual or surrogate ability to sign informed consent\n* negative, urine-based pregnancy test in females\n\nExclusion Criteria:\n\n* contraindication or intolerance to dornase alfa\n* mechanical ventilation expected to be less than 48 hours\n* life expectancy less than 24 hours based upon judgement of treating physician\n* pregnant\n* inability to obtain informed consent","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Arterial Blood Oxygen Content to Fraction of Inspired Oxygen Ratio (PaO2/FiO2)","description":"Daily evaluation of PaO2/FiO2 ratio at baseline prior to starting therapy and on days 1,2,3,4,5 and 14 if applicable","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.7","spread":null},{"groupId":"OG001","value":"21.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"61.1","spread":null},{"groupId":"OG001","value":"11.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.5","spread":null},{"groupId":"OG001","value":"12.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.1","spread":null},{"groupId":"OG001","value":"3.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"37.6","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"55","spread":null},{"groupId":"OG001","value":"-11.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Static Lung Compliance","description":"Daily evaluation of static lung compliance, measured by change in driving pressure over volume delivered, at baseline prior to starting therapy and on days 1,2,3,4,5 and 14 if applicable","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.1","spread":null},{"groupId":"OG001","value":"-0.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"-0.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.3","spread":null},{"groupId":"OG001","value":"-5.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"-5.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.4","spread":null},{"groupId":"OG001","value":"-4.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":null},{"groupId":"OG001","value":"-10.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Duration of Mechanical Ventilation","description":"Number of days on mechanical ventilation","paramType":"MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.2","spread":null},{"groupId":"OG001","value":"18.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Length of ICU Stay","description":"Number of days in the medical intensive care unit","paramType":"MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.5","spread":null},{"groupId":"OG001","value":"22.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Length of Hospitalization","description":"Number of days as an inpatient at the University of Missouri","paramType":"MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.5","spread":null},{"groupId":"OG001","value":"28.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Secondary Bacterial Infections","description":"Determination of secondary bacterial infections based upon positive culture results and clinical diagnosis by treating physician.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30","spread":null},{"groupId":"OG001","value":"25","spread":null}]}]}]},{"type":"SECONDARY","title":"Mortality","description":"All cause mortality","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"55","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":10},"commonTop":["Allergic reaction to drug"]}}}